FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147132034> ?p ?o ?g. }

• W2147132034 endingPage "49" @default.
• W2147132034 startingPage "41" @default.
• W2147132034 abstract "It has been known for many years that substantial weight loss, achieved by bariatric surgery or non-surgical means can mean normalize glucose tolerance. Recent randomized controlled trial evidence indicates that >15 kg weight loss is necessary, to this and it may lead to near normalization (doubling) of life expectancy. Less than 5% of patients achieve this through even the best, evidence-based medical weight management programme (Counterweight http://www.counterweight.org). A weight loss of >15 kg is easily achievable by 8 weeks very low-energy diet (VLED)/LELD (Low energy Liquid-formula Diet) in compliant patients, with little difference between 400 and 800 kcal day(-1) , but weight maintenance after VLED has until recently been so poor that VLED is not, at present, recommended in clinical guidelines. However, mean weight loss close to >15 kg can be maintained 18-24 months using a variety of maintenance strategies. These include a structured reintroduction of foods linked to an education programme with behavioural strategies, intermittent VLED use and prescribable anti-obesity drugs (dexfenfluramine, orlistat, sibutramine). Most of these studies have been in non-diabetic subjects. A new 'curative' paradigm in type 2 diabetes mellitus management, aiming to normalize glucose tolerance and health risks by achieving and maintaining >15 kg loss, as soon as possible after diagnosis, should be highly acceptable to patients, generating many additional Quality Adjusted Life Years (QALYs). It is likely to be highly cost-effective by avoiding the current recommended, mainly palliative, model, using polypharmacy which provides an overall risk reduction of only 5-10%. Clinical trials are on-going to establish the feasibility of delivering formula (LELD) and a maintenance programme to large numbers of patients within routine primary care. There is urgent need, to run similar studies in diabetic patients. New approaches to long-term (lifelong) maintenance of weight loss and a non-diabetic state may include anti-obesity drugs." @default.
• W2147132034 created "2016-06-24" @default.
• W2147132034 creator A5069996360 @default.
• W2147132034 date "2011-02-01" @default.
• W2147132034 modified "2023-10-14" @default.
• W2147132034 title "VLED and formula LED in the management of type 2 diabetes: defining the clinical need and research requirements" @default.
• W2147132034 cites W1665495983 @default.
• W2147132034 cites W1964227153 @default.
• W2147132034 cites W1966031472 @default.
• W2147132034 cites W1974783444 @default.
• W2147132034 cites W1976962580 @default.
• W2147132034 cites W1979724269 @default.
• W2147132034 cites W1992656515 @default.
• W2147132034 cites W1995864911 @default.
• W2147132034 cites W1998797154 @default.
• W2147132034 cites W1999414774 @default.
• W2147132034 cites W2003301702 @default.
• W2147132034 cites W2008075020 @default.
• W2147132034 cites W2014397018 @default.
• W2147132034 cites W2017776149 @default.
• W2147132034 cites W2019915404 @default.
• W2147132034 cites W2027681207 @default.
• W2147132034 cites W2028296353 @default.
• W2147132034 cites W2043072682 @default.
• W2147132034 cites W2044160793 @default.
• W2147132034 cites W2044790396 @default.
• W2147132034 cites W2076070753 @default.
• W2147132034 cites W2089342771 @default.
• W2147132034 cites W2089548707 @default.
• W2147132034 cites W2093587125 @default.
• W2147132034 cites W2098459806 @default.
• W2147132034 cites W2103074008 @default.
• W2147132034 cites W2104373595 @default.
• W2147132034 cites W2110791445 @default.
• W2147132034 cites W2119104951 @default.
• W2147132034 cites W2126470550 @default.
• W2147132034 cites W2128671643 @default.
• W2147132034 cites W2133783450 @default.
• W2147132034 cites W2145202496 @default.
• W2147132034 cites W2152835319 @default.
• W2147132034 cites W2327205299 @default.
• W2147132034 cites W3198570063 @default.
• W2147132034 cites W4255557649 @default.
• W2147132034 cites W4367329899 @default.
• W2147132034 doi "https://doi.org/10.1111/j.1758-8111.2010.00007.x" @default.
• W2147132034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25586974" @default.
• W2147132034 hasPublicationYear "2011" @default.
• W2147132034 type Work @default.
• W2147132034 sameAs 2147132034 @default.
• W2147132034 citedByCount "11" @default.
• W2147132034 countsByYear W21471320342012 @default.
• W2147132034 countsByYear W21471320342013 @default.
• W2147132034 countsByYear W21471320342015 @default.
• W2147132034 countsByYear W21471320342016 @default.
• W2147132034 countsByYear W21471320342017 @default.
• W2147132034 countsByYear W21471320342019 @default.
• W2147132034 countsByYear W21471320342022 @default.
• W2147132034 countsByYear W21471320342023 @default.
• W2147132034 crossrefType "journal-article" @default.
• W2147132034 hasAuthorship W2147132034A5069996360 @default.
• W2147132034 hasBestOaLocation W21471320342 @default.
• W2147132034 hasConcept C126322002 @default.
• W2147132034 hasConcept C134018914 @default.
• W2147132034 hasConcept C170493617 @default.
• W2147132034 hasConcept C177713679 @default.
• W2147132034 hasConcept C2775864247 @default.
• W2147132034 hasConcept C2777180221 @default.
• W2147132034 hasConcept C2777646958 @default.
• W2147132034 hasConcept C2779638493 @default.
• W2147132034 hasConcept C2780780548 @default.
• W2147132034 hasConcept C2781083316 @default.
• W2147132034 hasConcept C2910068830 @default.
• W2147132034 hasConcept C34320749 @default.
• W2147132034 hasConcept C511355011 @default.
• W2147132034 hasConcept C544821477 @default.
• W2147132034 hasConcept C555293320 @default.
• W2147132034 hasConcept C71924100 @default.
• W2147132034 hasConceptScore W2147132034C126322002 @default.
• W2147132034 hasConceptScore W2147132034C134018914 @default.
• W2147132034 hasConceptScore W2147132034C170493617 @default.
• W2147132034 hasConceptScore W2147132034C177713679 @default.
• W2147132034 hasConceptScore W2147132034C2775864247 @default.
• W2147132034 hasConceptScore W2147132034C2777180221 @default.
• W2147132034 hasConceptScore W2147132034C2777646958 @default.
• W2147132034 hasConceptScore W2147132034C2779638493 @default.
• W2147132034 hasConceptScore W2147132034C2780780548 @default.
• W2147132034 hasConceptScore W2147132034C2781083316 @default.
• W2147132034 hasConceptScore W2147132034C2910068830 @default.
• W2147132034 hasConceptScore W2147132034C34320749 @default.
• W2147132034 hasConceptScore W2147132034C511355011 @default.
• W2147132034 hasConceptScore W2147132034C544821477 @default.
• W2147132034 hasConceptScore W2147132034C555293320 @default.
• W2147132034 hasConceptScore W2147132034C71924100 @default.
• W2147132034 hasIssue "1" @default.
• W2147132034 hasLocation W21471320341 @default.
• W2147132034 hasLocation W21471320342 @default.
• W2147132034 hasLocation W21471320343 @default.
• W2147132034 hasOpenAccess W2147132034 @default.

• next